MA40920A - Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci - Google Patents

Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci

Info

Publication number: MA40920A
Authority: MA; Morocco
Prior art keywords: vaccines; foot; mouth; manufacturing; methods
Prior art date: 2014-11-07

Application number

MA040920A

Other languages

English (en)

Inventor

Subash Chandra Das

Jorge E Osorio

Joseph David Santangelo

Dan Thomas Stinchcomb

Original Assignee

Takeda Vaccines Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2014-11-07

Filing date

2015-11-05

Publication date

2017-09-12

2015-11-05 Application filed by Takeda Vaccines Inc filed Critical Takeda Vaccines Inc

2017-09-12 Publication of MA40920A publication Critical patent/MA40920A/fr

Links

238000004519 manufacturing process Methods 0.000 title 1
238000000034 method Methods 0.000 title 1
229960005486 vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/00051—Methods of production or purification of viral material
- C12N2770/00052—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32151—Methods of production or purification of viral material
- C12N2770/32152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32111—Aphthovirus, e.g. footandmouth disease virus
- C12N2770/32171—Demonstrated in vivo effect
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32361—Methods of inactivation or attenuation
- C12N2770/32363—Methods of inactivation or attenuation by chemical treatment
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32311—Enterovirus
- C12N2770/32371—Demonstrated in vivo effect
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Microbiology (AREA)
Immunology (AREA)
Mycology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Wood Science & Technology (AREA)
Genetics & Genomics (AREA)
Zoology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Communicable Diseases (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Biomedical Technology (AREA)
Biochemistry (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Peptides Or Proteins (AREA)

MA040920A 2014-11-07 2015-11-05 Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci MA40920A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US201462077139P	2014-11-07	2014-11-07

Publications (1)

Publication Number	Publication Date
MA40920A true MA40920A (fr)	2017-09-12

Family

ID=55909911

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA040920A MA40920A (fr)	2014-11-07	2015-11-05	Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci

Country Status (14)

Country	Link
US (1)	US10806782B2 (fr)
EP (1)	EP3215621A4 (fr)
JP (1)	JP6839088B2 (fr)
KR (1)	KR20170082584A (fr)
CN (1)	CN107406856B (fr)
AR (1)	AR102547A1 (fr)
AU (2)	AU2015342829A1 (fr)
CA (1)	CA2965994A1 (fr)
HK (1)	HK1244508A1 (fr)
MA (1)	MA40920A (fr)
SG (1)	SG11201703711RA (fr)
TW (1)	TWI737584B (fr)
UY (1)	UY36395A (fr)
WO (1)	WO2016073929A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2015252119A1 (en)	2014-11-07	2016-05-26	Takeda Vaccines, Inc.	Hand, foot, and mouth vaccines and methods of manufacture and use thereof
AR102547A1 (es)	2014-11-07	2017-03-08	Takeda Vaccines Inc	Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso
CN106520789B (zh) *	2015-09-09	2019-05-10	中国人民解放军军事医学科学院微生物流行病研究所	一种dna分子与重组病毒及它们的制备方法和用途
CN106636001B (zh) *	2016-12-29	2020-07-31	汕头大学医学院	一种重组肠道病毒表型混合系统的构建方法和应用
CN111050795B (zh) *	2017-07-03	2023-09-22	巴拉特生物技术国际有限公司	基于合成的多肽表位的疫苗组合物
KR20200117981A (ko)	2017-11-03	2020-10-14	다케다 백신즈 인코포레이티드	지카 백신 및 면역원성 조성물, 그리고 이를 이용하는 방법들
MX2020005554A (es)	2017-11-30	2020-10-12	Takeda Vaccines Inc	Vacunas y composiciones inmunogenas para zika y metodos para usarlas.
CN109182496A (zh) *	2018-09-20	2019-01-11	西安交通大学医学院第二附属医院	一种ev71感染和重症化风险检测试剂盒及其应用
SG11202106394PA (en) *	2018-12-29	2021-07-29	Bharat Biotech Int Ltd	Adaptation of enterovirus to vero cells and vaccine formulations thereof
CN110184242B (zh) *	2019-06-11	2021-08-20	武汉生物制品研究所有限责任公司	柯萨奇病毒a组6型(cva6)的小鼠强毒力攻毒株及其应用
BR112022015710A2 (pt) *	2020-02-27	2022-09-27	Takeda Vaccines Inc	Método para remover dna de célula hospedeira a partir da preparação de vírus
WO2022070210A1 (fr) *	2020-09-29	2022-04-07	Bharat Biotech International Limited	Formulations stables de vaccins contre des entérovirus à faible abondance et leur procédé de fabrication
CN114807060B (zh) *	2022-06-23	2022-09-30	北京民海生物科技有限公司	柯萨奇病毒a6型毒株及其免疫原性组合物和应用

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3238190A (en)	1963-10-23	1966-03-01	Madaus & Co K G Fa Dr	Aescin recovery
FR2475572A1 (fr)	1980-02-11	1981-08-14	Pasteur Institut	Procede pour l'obtention de fragments de virus a enveloppe lipidique, en particulier d'antigenes utilisables comme vaccins, produits obtenus et applications
US4596556A (en)	1985-03-25	1986-06-24	Bioject, Inc.	Hypodermic injection apparatus
CA1331443C (fr)	1987-05-29	1994-08-16	Charlotte A. Kensil	Adjuvant a saponine
US5057540A (en)	1987-05-29	1991-10-15	Cambridge Biotech Corporation	Saponin adjuvant
US5278302A (en)	1988-05-26	1994-01-11	University Patents, Inc.	Polynucleotide phosphorodithioates
ATE115862T1 (de)	1989-02-04	1995-01-15	Akzo Nobel Nv	Tocole als impfstoffadjuvans.
CA2017507C (fr)	1989-05-25	1996-11-12	Gary Van Nest	Adjuvant constitue d'une emulsion de gouttelettes submicron d'huile
FR2649013B1 (fr)	1989-07-03	1991-10-25	Seppic Sa	Vaccins et vecteurs de principes actifs fluides contenant une huile metabolisable
FR2649012B1 (fr)	1989-07-03	1991-10-25	Seppic Sa	Emulsions multiphasiques injectables
EP0468520A3 (en)	1990-07-27	1992-07-01	Mitsui Toatsu Chemicals, Inc.	Immunostimulatory remedies containing palindromic dna sequences
US5776468A (en)	1993-03-23	1998-07-07	Smithkline Beecham Biologicals (S.A.)	Vaccine compositions containing 3-0 deacylated monophosphoryl lipid A
GB9326253D0 (en)	1993-12-23	1994-02-23	Smithkline Beecham Biolog	Vaccines
WO1995026204A1 (fr)	1994-03-25	1995-10-05	Isis Pharmaceuticals, Inc.	Stimulation immunitaire par des analogues d'oligonucleotides de phosphorothioate
EP1167379A3 (fr)	1994-07-15	2004-09-08	University Of Iowa Research Foundation	Oligonucléotides immunomodulateurs
US5666153A (en)	1995-10-03	1997-09-09	Virtual Shopping, Inc.	Retractable teleconferencing apparatus
DE19612966B4 (de)	1996-04-01	2009-12-10	Novartis Vaccines And Diagnostics Gmbh & Co. Kg	MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
DE19612967A1 (de)	1996-04-01	1997-10-02	Behringwerke Ag	Verfahren zur Vermehrung von Influenzaviren in Zellkultur, sowie die durch das Verfahren erhältlichen Influenzaviren
CA2253549C (fr)	1996-06-18	2005-10-25	Alza Corporation	Dispositif d'amelioration d'apport ou d'echantillonnage d'agents transdermiques
US5856462A (en)	1996-09-10	1999-01-05	Hybridon Incorporated	Oligonucleotides having modified CpG dinucleosides
US5980898A (en)	1996-11-14	1999-11-09	The United States Of America As Represented By The U.S. Army Medical Research & Material Command	Adjuvant for transcutaneous immunization
EP0957972B1 (fr)	1996-12-20	2003-03-19	Alza Corporation	Dispositif et procede permettant d'ameliorer le flux d'agent transdermique
US6113918A (en)	1997-05-08	2000-09-05	Ribi Immunochem Research, Inc.	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6355257B1 (en)	1997-05-08	2002-03-12	Corixa Corporation	Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US5993412A (en)	1997-05-19	1999-11-30	Bioject, Inc.	Injection apparatus
GB9711990D0 (en)	1997-06-11	1997-08-06	Smithkline Beecham Biolog	Vaccine
GB9718901D0 (en)	1997-09-05	1997-11-12	Smithkline Beecham Biolog	Vaccine
AU1145699A (en)	1997-09-05	1999-03-22	Smithkline Beecham Biologicals (Sa)	Oil in water emulsions containing saponins
EP1021548A1 (fr)	1997-10-07	2000-07-26	University Of Maryland Biotechnology Institute	Procede d'introduction et d'expression d'arn dans des cellules animales
CA2312900A1 (fr)	1997-12-02	1999-06-10	Powderject Vaccines, Inc.	Administration transdermique de compositions particulaires de vaccins
GB9727262D0 (en)	1997-12-24	1998-02-25	Smithkline Beecham Biolog	Vaccine
WO1999052549A1 (fr)	1998-04-09	1999-10-21	Smithkline Beecham Biologicals S.A.	Compositions adjuvantes
PT1104306E (pt)	1998-08-10	2006-05-31	Antigenics Inc	Composicoes de cpg e adjuvantes de saponina e seus metodos
DE69935927T2 (de)	1998-12-02	2008-01-10	University Of Maryland, Baltimore	Plasmidstabilisierungssystem für die verabreichung von antigenen
US6492169B1 (en)	1999-05-18	2002-12-10	Crucell Holland, B.V.	Complementing cell lines
EP1103610A1 (fr)	1999-11-26	2001-05-30	Introgene B.V.	Production de vaccins de lignées de cellules mammifère immortalisées
FR2810888B1 (fr)	2000-06-29	2004-07-30	Merial Sas	Vaccin contre la fievre aphteuse
JP3976685B2 (ja)	2000-11-22	2007-09-19	ユニバーシティオブメリーランド，ボルチモア	タンパク質分泌のためのＣｌｙＡ溶血素の使用
KR100401423B1 (ko) *	2001-01-10	2003-10-17	주식회사 엘지생명과학	혼합 백신의 제조 방법
ATE489965T1 (de)	2004-09-09	2010-12-15	Novartis Vaccines & Diagnostic	Verminderung von potentiellen iatrogenen risiken in verbindung mit influenza impfstoffen
CN101575593B (zh)	2009-06-03	2012-07-04	北京科兴生物制品有限公司	手足口病疫苗及其制备方法和应用
CN101897963B (zh) *	2010-03-18	2012-07-25	北京绿竹生物技术有限责任公司	一种手足口病病毒疫苗
CN102220288B (zh) *	2011-05-04	2013-07-17	中国科学院上海巴斯德研究所	一种肠道病毒ev71型鼠适应株573及其应用
US20150044257A1 (en) *	2012-03-23	2015-02-12	Fred Hutchinson Cancer Research Center	Baculovirus-based enterovirus 71 vlp as a vaccine
CN103834618B (zh) *	2012-11-28	2016-09-14	中国科学院上海巴斯德研究所	一种能有效感染小鼠的柯萨奇a16型病毒突变株
MY185184A (en)	2013-01-18	2021-04-30	Temasek Life Sciences Laboratory Ltd	Cold-adapted temperature sensitive strains of enterovirus 71 and processes of developing cold-adapted temperature sensitive virus strains
CN105338998B (zh)	2013-03-15	2021-12-14	宾夕法尼亚大学理事会	口蹄疫病毒(fmdv)共有蛋白、其编码序列以及由其制造的疫苗
AU2015252119A1 (en)	2014-11-07	2016-05-26	Takeda Vaccines, Inc.	Hand, foot, and mouth vaccines and methods of manufacture and use thereof
AR102547A1 (es)	2014-11-07	2017-03-08	Takeda Vaccines Inc	Vacunas contra la enfermedad de manos, pies y boca y métodos de fabricación y su uso

2015
- 2015-11-05 AR ARP150103593A patent/AR102547A1/es unknown
- 2015-11-05 MA MA040920A patent/MA40920A/fr unknown
- 2015-11-06 SG SG11201703711RA patent/SG11201703711RA/en unknown
- 2015-11-06 AU AU2015342829A patent/AU2015342829A1/en not_active Abandoned
- 2015-11-06 CA CA2965994A patent/CA2965994A1/fr not_active Abandoned
- 2015-11-06 UY UY0001036395A patent/UY36395A/es not_active Application Discontinuation
- 2015-11-06 KR KR1020177015451A patent/KR20170082584A/ko not_active Ceased
- 2015-11-06 HK HK18103931.6A patent/HK1244508A1/zh unknown
- 2015-11-06 US US15/524,939 patent/US10806782B2/en not_active Expired - Fee Related
- 2015-11-06 WO PCT/US2015/059587 patent/WO2016073929A1/fr not_active Ceased
- 2015-11-06 TW TW104136745A patent/TWI737584B/zh not_active IP Right Cessation
- 2015-11-06 CN CN201580072519.3A patent/CN107406856B/zh not_active Expired - Fee Related
- 2015-11-06 EP EP15857562.1A patent/EP3215621A4/fr not_active Withdrawn
- 2015-11-06 JP JP2017543336A patent/JP6839088B2/ja not_active Expired - Fee Related
2022
- 2022-04-27 AU AU2022202779A patent/AU2022202779A1/en not_active Abandoned

Also Published As

Publication number	Publication date
AU2015342829A1 (en)	2017-05-25
KR20170082584A (ko)	2017-07-14
JP6839088B2 (ja)	2021-03-03
AU2022202779A1 (en)	2022-05-19
TW201631159A (zh)	2016-09-01
AR102547A1 (es)	2017-03-08
CA2965994A1 (fr)	2016-05-12
CN107406856A (zh)	2017-11-28
JP2017535602A (ja)	2017-11-30
SG11201703711RA (en)	2017-06-29
EP3215621A1 (fr)	2017-09-13
WO2016073929A1 (fr)	2016-05-12
US10806782B2 (en)	2020-10-20
UY36395A (es)	2016-06-30
HK1244508A1 (zh)	2018-08-10
CN107406856B (zh)	2022-02-11
TWI737584B (zh)	2021-09-01
US20180125965A1 (en)	2018-05-10
EP3215621A4 (fr)	2018-06-27

Publication	Publication Date	Title
MA40920A (fr)	2017-09-12	Vaccins de la main, du pied et de la bouche, et procédés de fabrication et d'utilisation de ceux-ci
EP3490539A4 (fr)	2020-08-12	Nouvelle formulation par voie orale.
EP3513667A4 (fr)	2020-06-10	Inhalateur d'arôme
EP3440948A4 (fr)	2019-12-18	Inhalateur d'arôme
EP3348327A4 (fr)	2019-05-01	Épurateur d'air
EP3313404A4 (fr)	2019-08-07	Compositions thérapeutiques, associations et procédés d'utilisation
HUE040395T2 (hu)	2019-03-28	Ápolóeszköz és eljárás
IL260718B (en)	2020-09-30	Oral treatment compounds and methods of using the compounds
HUE052095T2 (hu)	2021-04-28	Keratin kezelési készítmények és eljárások
EP3391954A4 (fr)	2019-02-20	Épurateur d'air
HUE050306T2 (hu)	2020-11-30	Orális vízfelvevõ kompozíció, és ennek eljárásai
IL251379A0 (en)	2017-05-29	Compositions for oral care containing zinc, arginine and serine
BR112017017199A2 (pt)	2018-06-26	instrumento para higiene bucal
IL259239B (en)	2021-02-28	Oral care compounds and methods
PL3157901T3 (pl)	2018-08-31	Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki
DK3244920T5 (da)	2024-10-07	Mund- og klovsyge-vaccine
EP2981529A4 (fr)	2016-12-07	Analogues d'oridonine, compositions et procédés associés
ZA201902622B (en)	2022-12-21	Oral care composition
ZA201902623B (en)	2022-12-21	Oral care composition
ZA201801015B (en)	2019-07-31	Oral care compositions and methods of using the compositions
IL251345A0 (en)	2017-05-29	Compositions for use in the treatment of peri-implantitis
DK3253868T3 (da)	2020-04-27	Sammensætninger og fremgangsmåder, der omfatter anvendelsen af en bacillus agaradhaerens inulosucrase (inou)
ZA201903378B (en)	2022-12-21	Oral care composition
IL258304A (en)	2018-05-31	Oral care compounds and methods for using the compounds
EP3346240A4 (fr)	2019-04-17	Débitmètre d'air